Evidence map›Paper›PMID 35702051›Full record

ArticleTrends in hearing

The Concurrent OLSA Test: A Method for Speech Recognition in Multi-talker Situations at Fixed SNR.

Jan Heeren, Theresa Nuesse, Matthias Latzel, Inga Holube, Volker Hohmann, Kirsten C Wagener, Michael Schulte

Abstract read
In one paragraph

Article in Trends in hearing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jan HeerenHörzentrum Oldenburg gGmbH, Oldenburg, Germany.ORCID 0000-0002-8489-8705
Theresa NuesseCluster of Excellence Hearing4All, Oldenburg, Germany.ORCID 0000-0002-6202-8952
Matthias LatzelSonova AG, Stäfa, Switzerland.
Inga HolubeCluster of Excellence Hearing4All, Oldenburg, Germany.
Volker HohmannHörzentrum Oldenburg gGmbH, Oldenburg, Germany.
Kirsten C WagenerHörzentrum Oldenburg gGmbH, Oldenburg, Germany.ORCID 0000-0003-2858-2789
Michael SchulteHörzentrum Oldenburg gGmbH, Oldenburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multi-talker paradigm is introduced that uses different attentional processes to adjust speech-recognition scores with the goal of conducting measurements at high signal-to-noise ratios (SNR). The basic idea is to simulate a group conversation with three talkers. Talkers alternately speak sentences of the German matrix test OLSA. Each time a sentence begins with the name "Kerstin" (call sign), the participant is addressed and instructed to repeat the last words of all sentences from that talker, until another talker begins a sentence with "Kerstin". The alternation of the talkers is implemented with an adjustable overlap time that causes an overlap between the call sign "Kerstin" and the target words to be repeated. Thus, the two tasks of detecting "Kerstin" and repeating target words are to be done at the same time. The paradigm was tested with 22 young normal-hearing participants (YNH) for three overlap times (0.6 s, 0.8 s, 1.0 s). Results for these overlap times show significant differences, with median target word recognition scores of 88%, 82%, and 77%, respectively (including call-sign and dual-task effects). A comparison of the dual task with the corresponding single tasks suggests that the observed effects reflect an increased cognitive load.

Indexed as

SpeechSpeech PerceptionHearing TestsHumansLanguageSignal-To-Noise Ratioattentioncocktail partyconcurrent speechOLSAspeech-in-speechspeech recognition

Identifiers

PMID35702051
PMCPMC9208053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.